Microbot Medical's EPS (Basic) for the
three
months ended in Dec. 2023 was $-0.26.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.08.
During the past 3 years, the average EPS without NRIGrowth Rate was 9.30% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 11.20% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 45.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, Microbot Medical's highest 3-Year average EPS without NRI Growth Rate was 87.10% per year. The lowest was -14.90% per year. And the median was 14.60% per year.
Microbot Medical EPS (Diluted) Historical Data
The historical data trend for Microbot Medical's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Microbot Medical's EPS (Diluted)
For the Medical Instruments & Supplies subindustry, Microbot Medical's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Microbot Medical's PE Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's PE Ratio distribution charts can be found below:
* The bar in red indicates where Microbot Medical's PE Ratio falls into.
Microbot Medical EPS (Diluted) Calculation
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
Microbot Medical's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.08
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microbot Medical (NAS:MBOT) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Microbot Medical EPS (Diluted) Related Terms
Thank you for viewing the detailed overview of Microbot Medical's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Microbot Medical (Microbot Medical) Business Description
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MBOT has been successfully added to your 